Kern Pharma generic medicines

Kern Pharma is a prominent Spanish pharmaceutical laboratory established in 1999. It specializes in the development, manufacture, and marketing of generic medicines, covering a wide range of therapeutic areas such as the central nervous system, cardiovascular health, and digestive health. The brand was born when the Indukern Group acquired the manufacturing facility of Roche in Terrassa, Spain, transforming it into a hub for affordable, high-quality generic healthcare solutions.

Over the decades, Kern Pharma has solidified its position as a leader in the Spanish generics market while expanding its reach internationally. The company operates a massive production plant in Terrassa, which serves as its primary manufacturing base. The brand is known for its commitment to sustainability and innovation, maintaining a robust pipeline of biosimilar and generic products that cater to both hospital and retail pharmacy sectors.

The ultimate ownership of Kern Pharma rests with the Indukern Group (Grupo Indukern), a family-owned multinational headquartered in Barcelona, Spain. The group was founded by José Luis Díaz-Varela and remains a private entity controlled by the Díaz-Varela family. This structure ensures that Kern Pharma operates with a long-term strategic vision focused on the European pharmaceutical landscape.